These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6607744)

  • 41. Fibrinolytic properties of activated FXII.
    Braat EA; Dooijewaard G; Rijken DC
    Eur J Biochem; 1999 Aug; 263(3):904-11. PubMed ID: 10469157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of human Hageman factor by Pseudomonas aeruginosa elastase in the presence or absence of negatively charged substance in vitro.
    Yamamoto T; Shibuya Y; Nishino N; Okabe H; Kambara T
    Biochim Biophys Acta; 1990 Apr; 1038(2):231-9. PubMed ID: 1691924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The bradykinin-forming cascade: a historical perspective.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).
    Griffin JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1998-2002. PubMed ID: 273926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Explicit constants for the dextran-sulfate-mediated activation and autoactivation of purified human factor XII (Hageman factor).
    Loiseau C; Randriamahazaka HN; Nigretto JM
    Eur J Biochem; 1996 Aug; 239(3):692-701. PubMed ID: 8774715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The autoactivation of factor XII in the presence of long-chain saturated fatty acids--a comparison with the potency of sulphatides and dextran sulphate.
    Mitropoulos KA; Esnouf MP
    Thromb Haemost; 1991 Oct; 66(4):446-52. PubMed ID: 1796394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Moderation of prekallkrein-factor XII interactions in surface activation of coagulation by protein-adsorption competition.
    Chatterjee K; Thornton JL; Bauer JW; Vogler EA; Siedlecki CA
    Biomaterials; 2009 Oct; 30(28):4915-20. PubMed ID: 19552950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The surface-dependent autoactivation mechanism of factor XII.
    Røjkjaer R; Schousboe I
    Eur J Biochem; 1997 Jan; 243(1-2):160-6. PubMed ID: 9030735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.
    Citarella F; Ravon DM; Pascucci B; Felici A; Fantoni A; Hack CE
    Eur J Biochem; 1996 May; 238(1):240-9. PubMed ID: 8665943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prekallikrein activation and kallikrein inactivation in human plasma.
    van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN
    Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365
    [No Abstract]   [Full Text] [Related]  

  • 51. Autoactivation of human plasma prekallikrein.
    Tans G; Rosing J; Berrettini M; Lämmle B; Griffin JH
    J Biol Chem; 1987 Aug; 262(23):11308-14. PubMed ID: 2440889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoactivation of human blood coagulation factor XII on dextran derivatives of different molecular weight.
    Tazi S; Tans G; Hemker HC; Nigretto JM
    Thromb Res; 1992 Sep; 67(6):665-76. PubMed ID: 1279836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prekallikrein activation in human, bovine, and rabbit plasmas: presence of an inhibitor in bovine plasma.
    Weerasinghe KM
    Inflammation; 1992 Jun; 16(3):205-13. PubMed ID: 1500097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I.
    Schousboe I; Rasmussen MS
    Thromb Haemost; 1995 May; 73(5):798-804. PubMed ID: 7482406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Activation of prekallikrein from human blood serum by different activators].
    Iarovaia GA; Dotsenko VL; Krizhevskaia IuV; Morozova NA; Orekhovich VN
    Biokhimiia; 1979 Jul; 44(7):1279-85. PubMed ID: 497275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The assay of prekallikrein activator in human blood products.
    Snape TJ; Griffith D; Vallet L; Wesley ED
    Dev Biol Stand; 1979; 44():115-20. PubMed ID: 317467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demonstration of a threshold response in a proteolytic feedback system: control of the autoactivation of factor XII.
    Jesty J; Rodriguez J; Beltrami E
    Pathophysiol Haemost Thromb; 2005; 34(2-3):71-9. PubMed ID: 16432309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.